Crispr Therapeutics shares owned by LPL Financial
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by LPL Financial
from 13F filings
Historical chart of LPL Financial investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by LPL Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $5.1M | 108k | 46.98 |
| 2024-06-30 | $6.3M | 116k | 54.01 |
| 2024-03-31 | $7.2M | 106k | 68.16 |
| 2023-09-30 | $4.1M | 91k | 45.39 |
| 2023-06-30 | $5.1M | 91k | 56.14 |
| 2023-03-31 | $3.7M | 82k | 45.23 |
| 2022-12-31 | $3.2M | 78k | 40.65 |
| 2022-09-30 | $5.1M | 78k | 65.35 |
| 2022-06-30 | $4.4M | 72k | 60.78 |
| 2022-03-31 | $4.1M | 65k | 62.76 |
| 2021-12-31 | $4.0M | 52k | 75.79 |
| 2021-09-30 | $6.2M | 55k | 111.93 |
| 2021-06-30 | $8.0M | 50k | 161.90 |
| 2021-03-31 | $5.6M | 46k | 121.84 |
| 2020-12-31 | $8.7M | 57k | 153.12 |
| 2020-09-30 | $3.1M | 37k | 83.64 |
| 2020-06-30 | $4.2M | 57k | 73.49 |
| 2020-03-31 | $941k | 22k | 42.39 |
| 2019-12-31 | $1.1M | 19k | 60.90 |
| 2019-09-30 | $537k | 13k | 40.98 |
| 2019-06-30 | $1.6M | 33k | 47.09 |
| 2019-03-31 | $295k | 8.3k | 35.75 |
| 2018-12-31 | $280k | 9.8k | 28.55 |
| 2018-09-30 | $350k | 7.9k | 44.39 |
| 2018-06-30 | $396k | 6.7k | 58.69 |
| 2018-03-31 | $256k | 5.6k | 45.63 |